The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| PROTEON THERAPEUTICS INC | COM | 74371L109 | 599 | 315,101 | SH | DFND | 1 | 315,101 | 0 | 0 | |
| CERULEAN PHARMA INC | COM | 15708Q105 | 118 | 166,675 | SH | DFND | 1 | 166,675 | 0 | 0 | |
| VERASTEM INC | COM | 92337C104 | 1,333 | 1,190,358 | SH | DFND | 1 | 1,190,358 | 0 | 0 | |
| MINDBODY INC | COM CL A | 60255W105 | 298 | 13,968 | SH | DFND | 1 | 13,968 | 0 | 0 | |